ArticleJAMA oncology2021

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.

Amir Massarweh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.